Moleculin Biotech Ownership 2024 | Who Owns Moleculin Biotech Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

17.39%

Insider Ownership

4.33%

Retail Ownership

78.28%

Institutional Holders

23.00

Moleculin Biotech Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-52	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-138	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-229	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-53,596	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-71,397	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-1,080,122	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-6,334	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-20,148	-100.00%	-	Mar 31, 2024
SCHMIDT P J INVESTMENT MANAGEMENT INC	-	-	-	-29,000	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-129,600	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-246,670	-100.00%	-	Mar 31, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-250	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-188,924	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-64,652	-100.00%	-	Mar 31, 2024
SIGMA PLANNING CORP	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
SANDY SPRING BANK	-	-	-	-1,333	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,201	-100.00%	-	Mar 31, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-3,207,417	-100.00%	-	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-2	-100.00%	-	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-968	-100.00%	-	Mar 31, 2024

Moleculin Biotech's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-52	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-138	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-229	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-53,596	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-71,397	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-1,080,122	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-6,334	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-20,148	-100.00%	-	Mar 31, 2024
SCHMIDT P J INVESTMENT MANAGEMENT INC	-	-	-	-29,000	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-129,600	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-246,670	-100.00%	-	Mar 31, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-250	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-188,924	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-64,652	-100.00%	-	Mar 31, 2024
SIGMA PLANNING CORP	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
SANDY SPRING BANK	-	-	-	-1,333	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,201	-100.00%	-	Mar 31, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-3,207,417	-100.00%	-	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-2	-100.00%	-	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-968	-100.00%	-	Mar 31, 2024

The largest Moleculin Biotech shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Moleculin Biotech (MBRX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NEWEDGE ADVISORS, LLC	-	-	-	-2	-100.00%	-	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	-	-52	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-138	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-229	-100.00%	-	Mar 31, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-250	-100.00%	-	Mar 31, 2024
CVA FAMILY OFFICE, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-968	-100.00%	-	Mar 31, 2024
SANDY SPRING BANK	-	-	-	-1,333	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-6,334	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,201	-100.00%	-	Mar 31, 2024
SIGMA PLANNING CORP	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
JMAC ENTERPRISES LLC	-	-	-	-13,132	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-20,148	-100.00%	-	Mar 31, 2024
SCHMIDT P J INVESTMENT MANAGEMENT INC	-	-	-	-29,000	-100.00%	-	Mar 31, 2024
ATTICUS WEALTH MANAGEMENT, LLC	-	-	-	-50,001	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-53,596	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-64,652	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-71,397	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-129,600	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-188,924	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Moleculin Biotech's largest institutional buyer is NEWEDGE ADVISORS, LLC. The company purchased -2.00 stocks of MBRX, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-3,207,417	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-1,080,122	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-246,670	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-188,924	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-129,600	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-71,397	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-64,652	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-53,596	-100.00%	-	Mar 31, 2024
ATTICUS WEALTH MANAGEMENT, LLC	-	-	-	-50,001	-100.00%	-	Mar 31, 2024
SCHMIDT P J INVESTMENT MANAGEMENT INC	-	-	-	-29,000	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-20,148	-100.00%	-	Mar 31, 2024
JMAC ENTERPRISES LLC	-	-	-	-13,132	-100.00%	-	Mar 31, 2024
SIGMA PLANNING CORP	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,201	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-6,334	-100.00%	-	Mar 31, 2024
SANDY SPRING BANK	-	-	-	-1,333	-100.00%	-	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-968	-100.00%	-	Mar 31, 2024
CVA FAMILY OFFICE, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-250	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-229	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Moleculin Biotech's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -3.21M shares of MBRX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-3,207,417	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-1,080,122	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-246,670	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-188,924	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-129,600	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-71,397	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-64,652	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-53,596	-100.00%	-	Mar 31, 2024
ATTICUS WEALTH MANAGEMENT, LLC	-	-	-	-50,001	-100.00%	-	Mar 31, 2024
SCHMIDT P J INVESTMENT MANAGEMENT INC	-	-	-	-29,000	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-20,148	-100.00%	-	Mar 31, 2024
JMAC ENTERPRISES LLC	-	-	-	-13,132	-100.00%	-	Mar 31, 2024
SIGMA PLANNING CORP	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,201	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-6,334	-100.00%	-	Mar 31, 2024
SANDY SPRING BANK	-	-	-	-1,333	-100.00%	-	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-968	-100.00%	-	Mar 31, 2024
CVA FAMILY OFFICE, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-250	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-229	-100.00%	-	Mar 31, 2024
BANK OF AMERICA CORP /DE/	-	-	-	-138	-100.00%	-	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	-	-52	-100.00%	-	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-2	-100.00%	-	Mar 31, 2024

Moleculin Biotech's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -3.21M shares, valued at -, as of undefined.

Moleculin Biotech Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	1,525,518	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	563,784	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	237,035	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	223,516	1,339	0.60%	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	21,052	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	18,118	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	5,479	-	-	Jan 31, 2024
ALLSPRING MASTER TRUST	0.00%	3,253	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	9,836	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	3,182	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	8,436	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	5,198	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,979	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	1,608	-	-	Mar 31, 2024

Moleculin Biotech's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 1.53M shares, compromising 0.00% of its total assets.

Moleculin Biotech Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	23	15.00%
30 Sep, 23	20	-9.09%
30 Jun, 23	22	-4.35%
31 Mar, 23	23	-4.17%
31 Dec, 22	24	14.29%
30 Sep, 22	21	-4.55%
30 Jun, 22	22	4.76%
31 Mar, 22	21	-8.70%
31 Dec, 21	23	4.55%
30 Sep, 21	22	-21.43%
30 Jun, 21	28	3.70%
31 Mar, 21	27	2600.00%
31 Dec, 20	1	-
30 Sep, 20	1	-
30 Jun, 20	1	-
31 Mar, 20	1	-
31 Dec, 19	1	-
30 Sep, 19	1	-
30 Jun, 19	1	-
31 Mar, 19	1	-

As of 31 Dec 23, 23 institutions are holding Moleculin Biotech's shares, representing an increase of 15.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	5,183,666	140.87%
30 Sep, 23	2,152,050	-5.84%
30 Jun, 23	2,285,496	-24.48%
31 Mar, 23	3,026,439	1.15%
31 Dec, 22	2,992,164	0.26%
30 Sep, 22	2,984,352	-0.43%
30 Jun, 22	2,997,387	1.42%
31 Mar, 22	2,955,289	-1.48%
31 Dec, 21	2,999,573	6.04%
30 Sep, 21	2,828,656	-3.47%
30 Jun, 21	2,930,396	39.22%
31 Mar, 21	2,104,900	630109.58%
31 Dec, 20	334	-
30 Sep, 20	334	-
30 Jun, 20	334	-
31 Mar, 20	334	-
31 Dec, 19	334	-
30 Sep, 19	334	-
30 Jun, 19	334	-
31 Mar, 19	334	-

Moleculin Biotech (MBRX) has 5.18M shares outstanding as of 31 Dec 23, up 140.87% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	17.39%	33.10%
30 Sep, 23	7.25%	11.47%
30 Jun, 23	7.95%	7.17%
31 Mar, 23	10.53%	9.62%
31 Dec, 22	10.46%	9.63%
30 Sep, 22	10.42%	9.48%
30 Jun, 22	10.49%	9.81%
31 Mar, 22	10.34%	8.30%
31 Dec, 21	11.16%	11.39%
30 Sep, 21	9.90%	9.33%
30 Jun, 21	10.30%	11.06%
31 Mar, 21	9.65%	12604191633.33%
31 Dec, 20	0.00%	333333.33%
30 Sep, 20	0.00%	333333.33%
30 Jun, 20	0.00%	333333.33%
31 Mar, 20	0.00%	333333.33%
31 Dec, 19	0.00%	333333.33%
30 Sep, 19	0.00%	333333.33%
30 Jun, 19	0.00%	333333.33%
31 Mar, 19	0.00%	-

As of 31 Dec 23, Moleculin Biotech is held by 17.39% institutional shareholders, representing a 33.10% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	10	100.00%
30 Sep, 23	5	-28.57%
30 Jun, 23	7	-36.36%
31 Mar, 23	11	-8.33%
31 Dec, 22	12	50.00%
30 Sep, 22	8	-
30 Jun, 22	8	-27.27%
31 Mar, 22	11	-8.33%
31 Dec, 21	12	71.43%
30 Sep, 21	7	-50.00%
30 Jun, 21	14	-46.15%
31 Mar, 21	26	-
31 Dec, 20	-	-
30 Sep, 20	-	-
30 Jun, 20	-	-
31 Mar, 20	-	-
31 Dec, 19	-	-
30 Sep, 19	-	-
30 Jun, 19	-	-100.00%
31 Mar, 19	1	-

10 institutional shareholders have increased their position in MBRX stock as of 31 Dec 23 compared to 5 in the previous quarter (a 100.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	4	-
30 Sep, 23	4	-20.00%
30 Jun, 23	5	66.67%
31 Mar, 23	3	-40.00%
31 Dec, 22	5	66.67%
30 Sep, 22	3	-62.50%
30 Jun, 22	8	166.67%
31 Mar, 22	3	50.00%
31 Dec, 21	2	-66.67%
30 Sep, 21	6	500.00%
30 Jun, 21	1	-
31 Mar, 21	-	-
31 Dec, 20	-	-
30 Sep, 20	-	-
30 Jun, 20	-	-
31 Mar, 20	-	-
31 Dec, 19	-	-
30 Sep, 19	-	-
30 Jun, 19	-	-
31 Mar, 19	-	-

4 institutional shareholders have reduced their position in MBRX stock as of 31 Dec 23 compared to 4 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	23	15.00%	5,183,666	140.87%	17.39%	33.10%	10	100.00%	4	-
30 Sep, 23	20	-9.09%	2,152,050	-5.84%	7.25%	11.47%	5	-28.57%	4	-20.00%
30 Jun, 23	22	-4.35%	2,285,496	-24.48%	7.95%	7.17%	7	-36.36%	5	66.67%
31 Mar, 23	23	-4.17%	3,026,439	1.15%	10.53%	9.62%	11	-8.33%	3	-40.00%
31 Dec, 22	24	14.29%	2,992,164	0.26%	10.46%	9.63%	12	50.00%	5	66.67%
30 Sep, 22	21	-4.55%	2,984,352	-0.43%	10.42%	9.48%	8	-	3	-62.50%
30 Jun, 22	22	4.76%	2,997,387	1.42%	10.49%	9.81%	8	-27.27%	8	166.67%
31 Mar, 22	21	-8.70%	2,955,289	-1.48%	10.34%	8.30%	11	-8.33%	3	50.00%
31 Dec, 21	23	4.55%	2,999,573	6.04%	11.16%	11.39%	12	71.43%	2	-66.67%
30 Sep, 21	22	-21.43%	2,828,656	-3.47%	9.90%	9.33%	7	-50.00%	6	500.00%
30 Jun, 21	28	3.70%	2,930,396	39.22%	10.30%	11.06%	14	-46.15%	1	-
31 Mar, 21	27	2600.00%	2,104,900	630109.58%	9.65%	12604191633.33%	26	-	-	-
31 Dec, 20	1	-	334	-	0.00%	333333.33%	-	-	-	-
30 Sep, 20	1	-	334	-	0.00%	333333.33%	-	-	-	-
30 Jun, 20	1	-	334	-	0.00%	333333.33%	-	-	-	-
31 Mar, 20	1	-	334	-	0.00%	333333.33%	-	-	-	-
31 Dec, 19	1	-	334	-	0.00%	333333.33%	-	-	-	-
30 Sep, 19	1	-	334	-	0.00%	333333.33%	-	-	-	-
30 Jun, 19	1	-	334	-	0.00%	333333.33%	-	-100.00%	-	-
31 Mar, 19	1	-	334	-	0.00%	-	1	-	-	-

Moleculin Biotech Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 05, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Sell	982	-	-	113,152
Jul 05, 2024	KLEMP WALTER V	director, officer	CEO and President	F-InKind	Sell	240	$3.57	$856.80	57,035
Jun 25, 2024	PICKER DONALD H	officer	Chief Science Officer	M-Exempt	Sell	1,766	-	-	26,358
Jun 25, 2024	Foster Jonathan P.	officer	Chief Financial Officer	M-Exempt	Sell	4,329	-	-	64,837
Jun 25, 2024	Foster Jonathan P.	officer	Chief Financial Officer	F-InKind	Sell	1,053	$3.74	$3.94K	11,363
Jun 25, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Sell	8,990	-	-	114,134
Jun 25, 2024	KLEMP WALTER V	director, officer	CEO and President	F-InKind	Sell	2,190	$3.74	$8.19K	56,293
Jun 21, 2024	PICKER DONALD H	officer	Chief Science Officer	M-Exempt	Sell	1,078	-	-	28,124
Jun 21, 2024	PICKER DONALD H	officer	Chief Science Officer	F-InKind	Sell	320	$3.78	$1.21K	6,759
Jun 21, 2024	Foster Jonathan P.	officer	Chief Financial Officer	M-Exempt	Sell	2,712	-	-	69,166
Jun 21, 2024	Foster Jonathan P.	officer	Chief Financial Officer	F-InKind	Sell	636	$3.78	$2.40K	8,087
Jun 21, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Sell	3,750	-	-	123,124

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 05, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Sell	982	-	-	113,152
Jul 05, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Buy	982	-	-	57,275
Jul 05, 2024	KLEMP WALTER V	director, officer	CEO and President	F-InKind	Sell	240	$3.57	$856.80	57,035
Jun 25, 2024	PICKER DONALD H	officer	Chief Science Officer	M-Exempt	Sell	1,766	-	-	26,358
Jun 25, 2024	PICKER DONALD H	officer	Chief Science Officer	M-Exempt	Buy	1,766	-	-	8,525
Jun 25, 2024	PICKER DONALD H	officer	Chief Science Officer	F-InKind	Buy	524	$3.74	$1.96K	8,001
Jun 25, 2024	Foster Jonathan P.	officer	Chief Financial Officer	M-Exempt	Sell	4,329	-	-	64,837
Jun 25, 2024	Foster Jonathan P.	officer	Chief Financial Officer	M-Exempt	Buy	4,329	-	-	12,416
Jun 25, 2024	Foster Jonathan P.	officer	Chief Financial Officer	F-InKind	Sell	1,053	$3.74	$3.94K	11,363
Jun 25, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Sell	8,990	-	-	114,134
Jun 25, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Buy	8,990	-	-	58,483
Jun 25, 2024	KLEMP WALTER V	director, officer	CEO and President	F-InKind	Sell	2,190	$3.74	$8.19K	56,293
Jun 21, 2024	PICKER DONALD H	officer	Chief Science Officer	M-Exempt	Sell	1,078	-	-	28,124
Jun 21, 2024	PICKER DONALD H	officer	Chief Science Officer	M-Exempt	Buy	1,078	-	-	7,079
Jun 21, 2024	PICKER DONALD H	officer	Chief Science Officer	F-InKind	Sell	320	$3.78	$1.21K	6,759
Jun 21, 2024	Foster Jonathan P.	officer	Chief Financial Officer	M-Exempt	Sell	2,712	-	-	69,166
Jun 21, 2024	Foster Jonathan P.	officer	Chief Financial Officer	M-Exempt	Buy	2,712	-	-	8,723
Jun 21, 2024	Foster Jonathan P.	officer	Chief Financial Officer	F-InKind	Sell	636	$3.78	$2.40K	8,087
Jun 21, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Sell	3,750	-	-	123,124
Jun 21, 2024	KLEMP WALTER V	director, officer	CEO and President	M-Exempt	Buy	3,750	-	-	50,407

The last insider sell of Moleculin Biotech's stock was made by KLEMP WALTER V on Jul 05 2024, selling 982 shares at - per share (valued at -).

Moleculin Biotech Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	5	10	50.00%
Q4 2023	3	-	-
Q3 2023	2	4	50.00%
Q2 2023	16	10	160.00%
Q4 2022	4	-	-
Q3 2022	2	8	25.00%
Q2 2022	22	4	550.00%
Q1 2022	1	-	-
Q3 2021	2	4	50.00%
Q2 2021	9	-	-
Q4 2020	1	-	-
Q3 2020	6	2	300.00%
Q2 2020	3	-	-
Q3 2019	7	-	-
Q2 2019	3	-	-
Q2 2018	7	-	-
Q4 2017	3	-	-
Q3 2017	3	2	150.00%
Q2 2017	4	-	-
Q3 2016	4	-	-

5 total buy trades, and 10 total sell trades (buy/sell ratio of 0.50%) were made by Moleculin Biotech's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q4 2023	3	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q4 2022	4	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q4 2020	-	-	-
Q3 2020	-	-	-
Q2 2020	-	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q2 2018	-	-	-
Q4 2017	-	-	-
Q3 2017	-	2	-
Q2 2017	4	-	-
Q3 2016	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Moleculin Biotech's stocks.

Moleculin Biotech Peer Ownership

Ticker	Company
PMVP	PMV Pharmaceuticals, Inc.
CFRX	ContraFect Corporation
PULM	Pulmatrix, Inc.
NXTC	NextCure, Inc.
CYCC	Cyclacel Pharmaceuticals, Inc.
IKT	Inhibikase Therapeutics, Inc.
BPTH	Bio-Path Holdings, Inc.
CAPR	Capricor Therapeutics, Inc.
DFFN	CervoMed Inc.
AKTX	Akari Therapeutics, Plc
ANTX	AN2 Therapeutics, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
ONTX	Traws Pharma, Inc.
ATXI	Avenue Therapeutics, Inc.
CBIO	Gyre Therapeutics, Inc.

MBRX Ownership FAQ

Who Owns Moleculin Biotech?

Moleculin Biotech is owned by institutional shareholders (17.39%), insiders (4.33%), and public (78.28%). The largest institutional shareholder of Moleculin Biotech is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Moleculin Biotech?

Moleculin Biotech's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.

How many Moleculin Biotech shareholders are there?

As of Dec 2023, there are 23 institutional shareholders of Moleculin Biotech.

What percentage of Moleculin Biotech is owned by JPMORGAN CHASE & CO?

JPMORGAN CHASE & CO owns 0 shares of Moleculin Biotech, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

What percentage of Moleculin Biotech is owned by BANK OF AMERICA CORP /DE/?

As of Mar 2024, BANK OF AMERICA CORP /DE/ holds 0 shares of Moleculin Biotech (MBRX), compromising 0% of the company, valued at $0.

What percentage of Moleculin Biotech is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN is the third largest holder of Moleculin Biotech. The company owns 0 of the company's shares outstanding (worth $0).